| Literature DB >> 33938130 |
Jing Wang1, Pupu Ge1,2, Zehui Lei1,2, Zhe Lu1,2, Lihua Qiang1,2, Qiyao Chai1,2, Yong Zhang1, Dongdong Zhao1,2, Bingxi Li1, Jiaqi Su1,2, Ruchao Peng1, Yu Pang3, Yi Shi1,2, Yu Zhang4, George Fu Gao1,2, Xiao-Bo Qiu5, Cui Hua Liu1,2.
Abstract
Upon Mycobacterium tuberculosis (Mtb) infection, protein kinase G (PknG), a eukaryotic-type serine-threonine protein kinase (STPK), is secreted into host macrophages to promote intracellular survival of the pathogen. However, the mechanisms underlying this PknG-host interaction remain unclear. Here, we demonstrate that PknG serves both as a ubiquitin-activating enzyme (E1) and a ubiquitin ligase (E3) to trigger the ubiquitination and degradation of tumor necrosis factor receptor-associated factor 2 (TRAF2) and TGF-β-activated kinase 1 (TAK1), thereby inhibiting the activation of NF-κB signaling and host innate responses. PknG promotes the attachment of ubiquitin (Ub) to the ubiquitin-conjugating enzyme (E2) UbcH7 via an isopeptide bond (UbcH7 K82-Ub), rather than the usual C86-Ub thiol-ester bond. PknG induces the discharge of Ub from UbcH7 by acting as an isopeptidase, before attaching Ub to its substrates. These results demonstrate that PknG acts as an unusual ubiquitinating enzyme to remove key components of the innate immunity system, thus providing a potential target for tuberculosis treatment.Entities:
Keywords: zzm321990Mycobacterium tuberculosiszzm321990; NF-κB signaling; protein kinase G; ubiquitin ligase; ubiquitin-activating enzyme
Mesh:
Substances:
Year: 2021 PMID: 33938130 PMCID: PMC8183399 DOI: 10.15252/embr.202052175
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 9.071